Neotropix
Date | Investors | Amount | Round |
---|---|---|---|
$10.0m | Series A | ||
N/A | $1.4m | Early VC | |
Total Funding | AUD17.6m |
Related Content
Recent News about Neotropix
EditNeotropix operates in the health and wellness sector, focusing on the development and research of cannabidiol (CBD) products. The company targets individuals seeking natural remedies for anxiety, neural regeneration, and cancer treatment support. Neotropix's business model revolves around the extraction and formulation of CBD compounds from marijuana plants, which are then marketed and sold to consumers. Revenue is generated through direct sales of CBD products and potentially through partnerships with medical research institutions. The company leverages scientific research to validate the efficacy of its products, aiming to provide reliable and effective health solutions. Neotropix serves a growing market of health-conscious consumers looking for alternative treatments to traditional pharmaceuticals. The company’s commitment to research and innovation positions it as a key player in the evolving CBD industry.
Keywords: CBD, neural regeneration, anxiety relief, cancer treatment, natural remedies, health and wellness, cannabidiol, marijuana extraction, scientific research, alternative treatments.